Lung cancer is the number 1 cause of cancer deaths in the United States. The prognosis is quite grim with the exception of stage 1. When faced with several failed therapeutic regimens and rapid progression of the disease, considering alternative therapies such as radiopharmaceutical therapies may be an option. We describe the case of a 36-y-old man with lung adenocarcinoma who had imaging molecular characterization of his disease with F-18-FDG, Ga-68-DOTATATE, and F-18-fluoride PET/CT scans that were able to shed some light on molecular characterization of his disease and serve as a guide to potential targeted or personalized radiopharmaceutical therapeutic options.
机构:
Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO 63110 USAWashington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO 63110 USA
Parihar, Ashwin Singh
Wahl, Richard L.
论文数: 0引用数: 0
h-index: 0
机构:Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO 63110 USA
Wahl, Richard L.
Jahromi, Amin H.
论文数: 0引用数: 0
h-index: 0
机构:Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO 63110 USA
机构:
Sichuan Univ, West China Hosp, Dept Nucl Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R ChinaSichuan Univ, West China Hosp, Dept Nucl Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
Yao, Xilan
Ou, Xiaohong
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Dept Nucl Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R ChinaSichuan Univ, West China Hosp, Dept Nucl Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China